FORBES | The Biomedical Advanced Research and Development Authority (BARDA) has launched a new funding initiative called DRIVe (Division of Research, Innovation and Ventures). DRIVe’s mission is to accelerate research, development and availability of transformative countermeasures to protect Americans in the event of public health emergencies such as chemical, biological, radiological, or nuclear disasters or attacks. The DRIVe initiative builds on BARDA’s involvement in CARB-X. A commentary by Steve Brozak.